Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Liberia Seals Slum to Halt Ebola

By Drug Discovery Trends Editor | August 20, 2014

Liberia security forces, block a road near the West Point Ebola center as the government clamps down on the movement of people to prevent the spread of the Ebola virus in city Monrovia, Liberia, Wednesday, Aug. 20, 2014. Security forces deployed Wednesday to enforce a quarantine around a slum in the Liberian capital, stepping up the government’s fight to stop the spread of Ebola and unnerving residents. (AP Photo/Abbas Dulleh)Security forces blocked off a seaside slum in Liberia’s capital Wednesday, stepping up the government’s fight to stop the spread of Ebola, unnerving residents and reportedly sparking a protest.
 
In central Monrovia there were few cars or people about as nervous residents stayed inside after President Ellen Johnson Sirleaf ordered West Point sealed off and imposed a nighttime curfew, saying that authorities have not been able to curtail the spread of Ebola in the face of defiance of their recommendations.
 
Sirleaf also ordered gathering places like movie theaters and night clubs shut and put Dolo Town, 30 miles (50 kilometers) south of the capital, under quarantine as well.
 
“These measures are meant to save lives,” she said in an address Tuesday night.
 
Ebola has killed at least 1,229 of the more than 2,200 people it has sickened in Guinea, Liberia, Sierra Leone and Nigeria in the outbreak, according to World Health Organizations figures. Liberia has the highest death toll and its number of cases is rising the fastest.
 
Fear and tension are running high in the capital, especially in places like West Point where there is substantial mistrust of authority. Dead bodies are dumped daily in the streets by relatives who fear infection. Fearful residents call a government hotline to ask that they be removed, but they sometimes remain outside for hours or days.
 
On Wednesday, riot police and soldiers deployed to block anyone from entering or leaving West Point, which occupies a peninsula where the Mesurado River meets the Atlantic Ocean. Few roads go into the area, and major road runs along the base of the peninsula, serving as a barrier between the neighborhood and the rest of Monrovia. A coast guard boat was also patrolling the waters around the kilometer (.6 mile)-long peninsula.
 
A woman who called into a local radio station’s breakfast program said she was blocked in traffic because there was a protest in West Point by disgruntled youths opposed to the quarantine.
 
Residents of the slum looted an Ebola screening center over the weekend, accusing the government of bringing sick people from all over the city to their neighborhood.
 
While Sirleaf blamed the disease’s continued spread on people who have hidden the sick or defied orders against touching dead bodies, many Liberians feel their government isn’t doing enough to protect them from the dreaded disease.
 
One resident, Richard Kieh, told The Associated Press by phone that the community was in “disarray” following the arrival of forces on Wednesday morning.
 
“Prices of things have been doubled here,” he said.
 
The current outbreak is currently the most severe in Liberia and Sierra Leone, but the U.N. health agency said that there were encouraging signs that the tide was beginning to turn in Guinea. There is also hope that Nigeria has managed to contain the disease to only a few cases
 
Nigeria’s health minister, Onyebuchi Chukwu, said Tuesday that a fifth person had died of the disease in that country. All of Nigeria’s reported cases so far have been people who had direct contact with a Liberian-American man who was already infected when he arrived in the country on an airliner.
 
Date: August 20, 2014
Source: Associated Press

Filed Under: Drug Discovery

 

Related Articles Read More >

Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir
George Floyd mural
How the pandemic and George Floyd made clinical trial diversity a priority

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50